Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. IQ-AI Limited
  6. News
  7. Summary
    IQAI   JE00BD4H0R42

IQ-AI LIMITED

(IQAI)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about IQ-AI LIMITED
2021IQ-AI Prepares for Phase I Clinical Trial Launch
CI
2021IQ-Ai Limited and St. Jude Children's Hospital Enters into A Data Use Agreement
CI
2021IQ-AI Limited Announces Case Report on Clinical Value of IB Software
CI
2021IQ AI : Wins Europe Patent for MRI Processing Technology
MT
2021IQ-AI Limited Receives European Patent for 'Multiparameter Perfusion Imaging with Leaka..
CI
2021IQ-AI Limited Announces IB Software Chosen for Accuracy and Automation
CI
2021IQ-AI Limited Announces Board Changes
CI
2021IQ AI : Shares to Start Trading on OTCQB Venture Market in US
MT
2021Iq-Ai Limited Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021IQ-AI Limited Announces Its Synthetic T1+C Software Application Was Awarded A Patent by..
CI
2021Iq-Ai Limited Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2021IQ-AI Limited Commits to Phase 1 Study for Drug Candidate in the Treatment of Glioblast..
CI
2021IQ-AI Limited Announces "Gad Free" Imaging Update
CI
2020IQ-AI Limited Releases StoneChecker 20.12
CI
2020IQ AI : Subsidiary Upgrades IB Clinic Software Platform
MT
More most relevant news
All news about IQ-AI LIMITED
2021IQ-AI Prepares for Phase I Clinical Trial Launch
CI
2021IQ-Ai Limited and St. Jude Children's Hospital Enters into A Data Use Agreement
CI
2021IQ-AI Limited Announces Case Report on Clinical Value of IB Software
CI
2021IQ AI : Wins Europe Patent for MRI Processing Technology
MT
2021IQ-AI Limited Receives European Patent for 'Multiparameter Perfusion Imaging with Leaka..
CI
2021IQ-AI Limited Announces IB Software Chosen for Accuracy and Automation
CI
2021IQ-AI Limited Announces Board Changes
CI
2021IQ AI : Shares to Start Trading on OTCQB Venture Market in US
MT
2021Iq-Ai Limited Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021IQ-AI Limited Announces Its Synthetic T1+C Software Application Was Awarded A Patent by..
CI
More news
News in other languages on IQ-AI LIMITED
2021IQ-AI obtient un brevet européen pour une technologie de traitement de l'IRM
2021Les actions de IQ-AI vont commencer à être négociées sur le marché à terme de l'OTCQB a..
2020Une filiale d'IQ-AI met à niveau la plateforme logicielle de IB Clinic
2020Les actions de IQ-AI gagnent 16 % grâce à un partenariat avec la Mayo Clinic pour un pr..
2020La vente de logiciels au Montgomery Cancer Center, aux États-Unis, fait bondir IQ-AI de..
2020La FDA américaine approuve le logiciel de biopsie du foie, ce qui fait bondir IQ-AI de ..
2019IQ-AI Ltd fournit des prévisions de ventes pour 2019
More news
Press releases
2020IQ AI : Conversion of Loan Notes - Correction
PU
More press releases
Upcoming event on IQ-AI LIMITED